BOSTON and ROLLE, Switzerland, Oct. 22,
2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH),
a cloud-native software company and a leader in data-driven
medicine, today announced it will release its financial results for
the third quarter of fiscal year 2024 before U.S. markets open on
Tuesday, November 5, 2024. On that
day, SOPHiA GENETICS will host a conference call to discuss its
financial results as well as business outlook beginning at
8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.
The call will be webcast live on the SOPHiA GENETICS
Investor Relations Website. Additionally, a replay will be
available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a
mission to expand access to data-driven medicine by using AI to
deliver world-class care to patients with cancer and rare disorders
across the globe. It is the creator of the SOPHiA DDM™ Platform, a
cloud-native platform that analyzes complex multimodal data –
including genomics, radiomics, clinical, biological, and digital
pathology data – to generate real-time, actionable insights for a
broad global network of hospital, laboratory, and biopharma
institutions. For more information,
visit SOPHiAGENETICS.COM and connect with us
on LinkedIn.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-announce-financial-results-for-third-quarter-2024-on-november-5-2024-302281898.html
SOURCE SOPHiA GENETICS
